Upcoming Medical Conferences in San Diego

World Vaccine and Immunotherapy Congress West Coast 2018 is organized by Terrapinn Ltd and will be held from Nov 28 - 30, 2018 at Loews Coronado Bay Resort, San Diego, California, United States of America. After an incredibly successful inaugural year, the World Vaccine and Immunotherapy Congress is back in 2018 to bring you more content, learning and business development opportunities so you can take advantage of the rich biotech and funding environment that the West Coast offers. Whilst still focussing on the vaccine and immunotherapy industry the scope of the event has expanded considerably and will delve deeper into topics surrounding vaccine development, cancer immunotherapy, funding and partnerships as well as exploring new topics in clinical trials and development, bioprocessing, manufacture and delivery, and the development and use of antibodies for both infectious diseases and cancer. This is the congress for top decision makers of the vaccine and immunotherapy industry with both scientific and commercial interests, specifically interested in both learning and/or partnering. No matter where your interest lies we have content, networking and potential partners for you. What to Expect? Providing attendees one stop progressive scientific and strategic solutions to the vaccine and immunotherapy industry, through executive level commentary, case studies and real-time analysis from key stakeholders to bring about faster, more cost-effective and more efficacious vaccines. • Meet the key players from the Human Vaccines Project - including all five universities and academics centers involved as well as senior members of the Scientific Steering Committee. • Hear exciting research from some of the top cancer centers in the US as well as senior representatives of leading consortia, including the Parker Institute for Cancer Immunotherapy, the San Diego Center for Precision Immunotherapy, the California Institute for Biomedical Research and the MD Anderson Cancer Center amongst others. • Explore the latest methods and technologies that allow better understanding of the immune system and improve vaccine development and other immunotherapy approaches against infectious diseases and cancer. This includes integrating synthetic biology, omics, immune profiling, bioinformatics, systems biology and newgeneration adjuvants with break through immunotherapy immunomodulators like check point inhibitors and oncolytic viruses in combinational therapies. • Hear from C-Level executives from all the key vaccine developers and thought leaders from pharma, biotech’s, academics and government, in a combined scientific and commercial environment where CRO’s, CMO’s, EQM’s, Biotech’s and platform technology organisations can demonstrate their latest products and services and do business. • Listen to updates on the latest discoverystage infectious and non-infectious vaccines and hear clinical phase I, II and III data from leading biotech’s, big pharma and regulatory experts. • Discover new technology for the manufacture, delivery and administration of vaccines, considerations for the manufacture of novel immunotherapies and engineered antibody formats. Time: 6:00 am to 9:00 pm Prices: • 3 Day Standard Package - Group Booking USD $2,450 Book a group of 3+ before 28 September 2018 saving USD $270 per person • 3 Day Academic Package - Group Booking USD $1,225 Book a group of 3+ before 28 September 2018 saving USD $135 per person Additional details will be posted as soon as they are available.

3rd Annual Thrombotic Thrombocytopenic Purpura (TTP) - Thrombotic Microangiopathy (TMA) Workshop is organized by Jonathan Wood & Associates (JWA) and will be held on Nov 30, 2018 at San Diego, California, United States of America. Conference Description : The proposed workshop will aid attendees in staying abreast with the most recent advances in the field and will provide expert guidance and recommendations to facilitate integration of crucial developments in the treatment and management of TTP-TMA. This workshop will also enable additional discussions that will be critical to developing future research endeavors. Additional details will be posted as soon as they are available.

Clinical and Laboratory Diagnosis of Red Blood Cell Disorders: A Case-Based Algorithmic Approach is organized by Mayo Medical Laboratories (MML) and will be held on Nov 30, 2018 at Marriott Marquis San Diego Marina, San Diego, California, United States of America. The target audience for this medical event is Hematologists, oncologists, hematopathologists, and pathologists who provide care for patients with hematological disorders. This CME Conference has been approved for a maximum of 3.0 AMA PRA Category 1 Credits. Description: Using a case-based approach, the overall objective of this program is to provide an update on interpretation and optimal application of standard and evolving test repertoire to diagnosis of RBC disorders. Combining the clinical and laboratory experience of our faculty, we will illustrate the practical application of testing algorithms derived from the Mayo Clinic practice and illustrate how unnecessary, redundant, and costly laboratory tests can be eliminated while maintaining the highest quality medical care. Conference Objectives are: Upon completion of the conference, participants should be able to: • Describe the algorithmic strategy for the diagnostic workup of erythrocytosis and understand the causes of hereditary erythrocytosis. • Discuss the general approach to evaluation of hemolytic anemia. • Determine the approach to evaluating a patient with direct antiglobulin negative hemolytic anemia. • Discuss the approach to evaluating a patient suspected of hereditary hemolytic anemia. • Apply an algorithmic approach to thrombotic microangiopathies. Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in the courses. Additional details will be posted as soon as they are available.

60th American Society of Hematology (ASH) Annual Meeting & Exposition is organized by American Society of Hematology (ASH) and will be held from Dec 01 - 04, 2018 at San Diego Convention Center, San Diego, California, United States of America. This CME Conference has been approved for a maximum of 36.5 AMA PRA Category 1 Credits. Additional details will be posted as soon as they are available.

Musculoskeletal Ultrasound in Hemophilia Course is organized by University of California San Diego School of Medicine (UCSD SOM) and will be held from Dec 05 - 07, 2018 at Hemophilia & Thrombosis Treatment Center at UC San Diego Health, San Diego, California, United States of America. The target audience for this medical event is physicians, physician assistants, nurse practitioners, nurses, and physical therapists involved and/or interested in MSKUS as a point-of-care imaging tool to assist with diagnosis and treatment of joint pains in people with hemophilia. Other healthcare professionals involved in hemophilia clinical care may benefit from this education program as well. Pediatric practitioners welcomed; though readings mainly apply to adolescents and adults. This CME Conference has been approved for a maximum of 19.75 AMA PRA Category 1 Credits. Course Overview : The hands-on course developed to provide training in musculoskeletal ultrasound (MSKUS) specific to a hemophilic joint disease. The objective of the course is to enable hemophilia physicians to use MSKUS as a point-of-care imaging tool to assist with the diagnosis and treatment of joint pains. The course is geared towards hemophilic joint disease to recognize joint bleeding, synovial hypertrophy and synovitis, cartilage degradation, osteochondral lesions and other structural joint abnormalities. Leading MSK ultrasound experts will cover ultrasound scanning, sonoanatomy, and sociopathology pertaining to hemophilic joint disease through interactive lectures, case presentations, roundtable discussions, and advanced MSKUS imaging techniques including MSKUS examination of hemophilic joints. This program is currently the only hands-on scanning course that provides comprehensive training and experience in musculoskeletal ultrasound in hemophilia. Course Objectives : Upon completion of this activity, participants should be able to: • Describe MSKUS basics and knobology • Operate an ultrasound machine • Describe sonoanatomy of ankles, knees and elbows • Apply standard transducer positions for hemophilia joint ultrasound • Distinguish bloody from non-bloody effusions • Perform a diagnostic musculoskeletal ultrasound recognizing hemarthrosis, synovitis and structural abnormalities (meniscus, tendons, ligaments) • Quantify synovial hypertrophy and synovitis by Power Doppler • Quantify cartilage health and osteochondral lesions Additional details will be posted as soon as they are available.

International Critical Incident Stress Foundation (ICISF) Regional Training is organized by International Critical Incident Stress Foundation (ICISF) and will be held from Dec 06 - 09, 2018 at Crowne Plaza San Diego - Mission Valley, San Diego, California, United States of America. This CME Conference has been approved for a maximum of 7, 13 or 14 hours (depending on the course attended) of contact hours. Additional details will be posted as soon as they are available.

Women's Health for Primary Care is organized by Medical Education Resources (MER) and will be held from Dec 07 - 09, 2018 at Hotel del Coronado, Curio Collection by Hilton, San Diego, California, United States of America. The target audience for this medical event is primary care providers and other health professionals with updates in primary care medicine. This CME Conference has been approved for a maximum of 12.00 AMA PRA Category 1 Credits. Learning Objectives: Upon completion of this program, participants should be better able to: • Distinguish between ovulatory and anovulatory uterine bleeding and other menstrual abnormalities and select appropriate treatment options • Explain the process of menopausal transition (climacteric) and describe the potential risks/benefits of HRT option, especially in relation to breast cancer and cardiovascular disease • Describe the management of HPV infection and abnormal pap smear results • Diagnose and manage important infectious disease syndromes in a range of organbased systems (respiratory, gastrointestinal, skin and soft-tissue) • Describe important strategies for the evaluation of infections in immunocompromised hosts Learning Outcome: To provide updates in primary care medicine to office based providers. Additional details will be posted as soon as they are available.

Mastering Minimally-Invasive Smile Design is organized by Den-Mat (dm) Holdings, LLC and will be held from Dec 07 - 08, 2018 at DoubleTree by Hilton Hotel San Diego - Mission Valley, San Diego, California, United States of America. The target audience for this medical event is Dentists, Dental Hygienists, Office Managers, Patient/Treatment Coordinators. This CME conference has been approved for a maximum of 13 CE Credits. Course Description : Join us for two days of powerful continuing education and learn best practices from your peers who have built highly successful practices with minimally-invasive esthetics in a challenging economy. This course features an all new approach to esthetic dentistry. Learn case selection, smile design, preparation using a new Additive-Reductive Template (A.R.T.), and final finishing and seating of minimally-invasive veneers. You will also be exposed to practice marketing, patient communication, case acceptance and practice management skills to build a successful esthetics-oriented dental practice. Learning Objectives : • Learn both clinical and business implementation all in one course - all you need to make a difference in your practice right away! • Experience engaging and unique hands-on training with different veneer case types and small equipment and material demonstrations. • Discover a new additive-reductive template and process to minimize chair time and enable the most conservative preparation with the best esthetic outcome. • Make complex cases, simple - all with minimal tooth reduction. Learn to tackle challenging alignment and asymmetrical arch forms and many other complex cases. • Participate in a class discussion about case planning; bring your cases for personalized evaluation! Note : Register more than 6 weeks before an event an bring one team member FREE! Additional details will be posted as soon as they are available.

2018 ASCB | EMBO Meeting is organized by American Society for Cell Biology (ASCB) and will be held from Dec 08 - 12, 2018 at San Diego Convention Center, San Diego, California, United States of America. 2018 ASCB Doorstep Meeting Overview : This doorstep symposium features leaders in stem cell biology who have studied mechanisms by which stem cells respond to stress. One of the most interesting areas of stem cell biology concerns the mechanisms by which stem cells withstand stresses such as tissue injury. So far, most studies of stem cell function have been in normal tissues. Less is known about the mechanisms that maintain stem cells in damaged tissues. Replicative stress and the need to regenerate differentiated cells can deplete stem cells, requiring the induction of distinct mechanisms that ensure stem cell persistence beyond homeostasis. The meeting will provide an overview of the field, with significant time allotted for discussion and interaction between audience and speakers, with the goal of inspiring the ACSB community to tackle the cell biology of stem cells and tissue regeneration. Meeting Objectives : • To provide a concise overview of stem cell biology, as it pertains to cell biology research and tissue regeneration • To illustrate how studies of the cell provide insights into stem cell research • To encourage stem cell researchers to consider cell biology in their research • To provide attendees and speakers opportunities to interact with each other in order to provide a more intimate and in-depth experience Additional details will be posted as soon as they are available.

Ultrasound-Guided Joint Injection Training Course is organized by UC San Diego School of Medicine Continuing Medical Education and will be held on Dec 08, 2018 at UC San Diego Health - Hemophilia / Thrombosis, La Jolla, San Diego, California, United States of America. The target audience for this medical event is physicians, physician assistants, nurse practitioners, nurses, and physical therapists involved and/or interested in point-of care ultrasound-guided intraarticular interventions to manage hemophilic joint disease. Other healthcare professionals involved in hemophilia clinical care may benefit from this education program as well. This CME Conference has been approved for a maximum of 8 AMA PRA Category 1 Credits. Conference Description : Ultrasound-Guided Joint Injection Training Course, presented by the UC San Diego School of Medicine, is a 1-day hands-on course, to provide training in ultrasound-guided intraarticular needle placement, to perform joint injections and aspirations. Many practices caring for hemophilia patients have introduced musculoskeletal ultrasound for non-invasive management of painful hemophilic joints. Adding training to perform needle placement into joints using ultrasound guidance will greatly enhance providers’ ability to manage joint pains in the hemophilia population. Musculoskeletal disease is common in hemophilia. Hemophilic arthropathy is a frequent and debilitating comorbidity caused by frequent joint bleeding. The hallmark of hemophilic arthopathy is osteochondral destruction and soft tissue proliferation, causing pain. Treatment options are limited and chiefly comprise conservative measures such as the administration of clotting factor concentrates, physical therapy, and oral analgesics or anti-inflammatory medications, which are often used to delay surgical interventions such as joint replacement at younger ages. Intra-articular corticosteroid injections have been used to effectively treat joint pain and improve range of motion in patients with inflammatory or degenerative joint diseases since the 1950s, and are included in the American College of Rheumatology’s treatment guidelines for rheumatoid arthritis (RA) and osteoarthritis (OA). However, blind needle placement and fear to cause injury and bleeding in complicated hemophilic joints is a barrier to use this modality. Recently, it has been shown that ultrasound-guided needle placement for injections and aspirations in hemophilic arthropathy is safe and effective to reduce pain. This spurred interest amongst hemophilia providers to utilize intra-articular injections and joint aspiration for the management of hemophilic arthropathy. However, hemophilia providers are not trained to perform ultrasound-guided procedures. Conference Objectives are : • Describe techniques and protocols for performing ultrasound guided injections of elbow, knee, hip, ankle and foot • Review the benefits of guided versus unguided intra-articular injections • Describe the indications and contra-indications of performing ultrasound guided intra-articular injections • Perform ultrasound-guided needle placement into ankle, knees and elbows • Identify sonographic target interfaces for accurate injections of the elbow, knee, hip, ankle and foot • Operate a MSKUS machine to include beam steer and optimization techniques for needle visualization • Use the Color Flow and Power Doppler to visualize vessels • Practice various approaches to access the intraarticular space for needle placement based on underlying joint pathology • Apply sterile techniques for needle placement • Review advantages and limitations of current intraarticular treatment modalities for pain relief Additional details will be posted as soon as they are available.